Literature DB >> 32285184

Data-dependent normalization strategies for untargeted metabolomics-a case study.

Paula Cuevas-Delgado1, Danuta Dudzik1,2, Verónica Miguel3, Santiago Lamas3, Coral Barbas4.   

Abstract

Despite the recent advances in the standardization of untargeted metabolomics workflows, there is still a lack of attention to specific data treatment strategies that require deep knowledge of the biological problem and need to be applied after a well-thought out process to understand the effect of the practice. One of those strategies is data normalization. Data-driven assumptions are critical especially addressing unwanted variation present in the biological model as it can be the case in heterogeneous tissues, cells with different sizes or biofluids with different concentrations. Chronic kidney disease (CKD) is a widespread disorder affecting kidney structure and function. Animal models are being developed to be able to get valuable insights into the etiopathogenesis of the condition and effect of the treatments. Moreover, diagnosis and disease staging still require defining appropriate biomarkers. Untargeted metabolomics has the potential to deal with those challenges. Renal fibrosis is one of the consequences of kidney injury which greatly affects the concentration of metabolites in the same quantity of sample. To overcome this challenge, several data normalization strategies have been applied, following a multilevel normalization method with the overall aim of focussing on the relevant biological information and reducing the influence of disturbing factors. A comprehensive evaluation of the performance of the normalization strategies, both on methods assessing the intragroup variation and on the impact on differential analysis, is provided. Finally, we present evidence of the importance of biological-model-driven guided normalization methods and discuss multiple criteria that need to be taken into consideration to obtain robust and reliable data. Special concern is transmitted on the misleading conclusions that might be the consequence of inappropriate data pre-treatment solutions applied for untargeted methods. Graphical abstract.

Entities:  

Keywords:  Biomarker discovery; Capillary electrophoresis mass spectrometry; Data pre-treatment; Normalization; Tissue samples; Unwanted variation

Mesh:

Year:  2020        PMID: 32285184     DOI: 10.1007/s00216-020-02594-9

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  6 in total

1.  A shift from glycolytic and fatty acid derivatives toward one-carbon metabolites in the developing lung during transitions of the early postnatal period.

Authors:  Daniel D Lee; Sang Jun Park; Kirsten L Zborek; Margaret A Schwarz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-01-27       Impact factor: 5.464

2.  Parallel Metabolomic Profiling of Cerebrospinal Fluid, Plasma, and Spinal Cord to Identify Biomarkers for Spinal Cord Injury.

Authors:  Hua Yang; Pengwei Zhang; Min Xie; Jianxian Luo; Jing Zhang; Guowei Zhang; Yang Wang; Hongsheng Lin; Zhisheng Ji
Journal:  J Mol Neurosci       Date:  2021-09-09       Impact factor: 3.444

3.  Graph Properties of Mass-Difference Networks for Profiling and Discrimination in Untargeted Metabolomics.

Authors:  Francisco Traquete; João Luz; Carlos Cordeiro; Marta Sousa Silva; António E N Ferreira
Journal:  Front Mol Biosci       Date:  2022-07-22

Review 4.  Food Phenotyping: Recording and Processing of Non-Targeted Liquid Chromatography Mass Spectrometry Data for Verifying Food Authenticity.

Authors:  Marina Creydt; Markus Fischer
Journal:  Molecules       Date:  2020-08-31       Impact factor: 4.411

5.  Recurrent Topics in Mass Spectrometry-Based Metabolomics and Lipidomics-Standardization, Coverage, and Throughput.

Authors:  Evelyn Rampler; Yasin El Abiead; Harald Schoeny; Mate Rusz; Felina Hildebrand; Veronika Fitz; Gunda Koellensperger
Journal:  Anal Chem       Date:  2020-11-28       Impact factor: 6.986

6.  Fish Skin and Gill Mucus: A Source of Metabolites for Non-Invasive Health Monitoring and Research.

Authors:  Lada Ivanova; Oscar D Rangel-Huerta; Haitham Tartor; Mona C Gjessing; Maria K Dahle; Silvio Uhlig
Journal:  Metabolites       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.